Class Eligibility

All persons or entities in the United States who purchased branded Zymar or Zymaxid directly from any of the Defendants from and including June 15, 2010 through December 31, 2017.

Estimated Amount

Varies

Proof of Purchase

Yes

Case Name

Hartig v. Senju, et al.,
Case No. 1:14-­cv­-00719,
District Court for the District of Delaware

Case Summary

The lawsuit alleges that Defendants engaged in an unlawful scheme to eliminate or delay generic competition for gatifloxacin ophthalmic solution (generic versions of their branded drugs Zymar and Zymaxid), a drug used to treat eye infections such as bacterial conjunctivitis, in violation of the Sherman Act. Defendants have denied any liability for these claims and have asserted various defenses to the claims.

Settlement Pool

$9,000,000

Deadline

10/05/2018

Contact


Hartig Drug Company Inc. v. Senju Pharmaceutical Co. Ltd. Settlement
c/o GCG
PO Box 9349
Dublin, OH 43017-4249
866-285-5811

2 responses to “Zymar, Zymaxid Antitrust Direct Purchaser Class Action Settlement”

  1. ralph troisi says:

    sir,it has been a long time sence I purchased the eye care,i have no idea how many bottles I can claim without proof of purchase,please advise me.

    ADMIN – Hi Ralph,

    Your pharmacy probably has records.

  2. Vien Mac says:

    I NEED FREE MONEY HELP ME

    ADMIN – Hi Vien,

    We are not an assistance organization.

Leave a Reply

Your email address will not be published. Required fields are marked *